Jean Christophe Plantier

Summary

Affiliation: Rouen University Hospital
Country: France

Publications

  1. ncbi Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic
    Francis Barin
    Universite Francois Rabelais, Centre National de Référence du VIH and Inserm Espri EA 3856, Tours, France
    J Med Virol 78:S13-8. 2006
  2. ncbi Plasma RNA quantification and HIV-1 divergent strains
    Jean Christophe Plantier
    Laboratoire de Virologie, GRAM IFR 23 CHU Charles Nicolle, Rouen, France
    J Acquir Immune Defic Syndr 33:1-7. 2003
  3. ncbi Plasma viral RNA assay in HIV-1 group O infection by real-time PCR
    Marie Gueudin
    Laboratoire de Virologie, Hopital Charles Nicolle, 1 rue de Germont, 76031 Rouen, France
    J Virol Methods 113:43-9. 2003
  4. ncbi Differences in proviral DNA load between HIV-1- and HIV-2-infected patients
    Marie Gueudin
    Laboratoire de Virologie, CHU Charles Nicolle Rouen, France
    AIDS 22:211-5. 2008
  5. ncbi Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide
    Agnès Depatureaux
    Laboratoire associé au Centre National de Référence du VIH, EA2656, CHU Charles Nicolle, Rouen, France
    Antimicrob Agents Chemother 54:4016-9. 2010
  6. ncbi French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002
    Diane Descamps
    Laboratoire de Virologie, CHU Bichat Claude Bernard, Paris, France
    J Acquir Immune Defic Syndr 38:545-52. 2005
  7. ncbi Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M
    Agnès Depatureaux
    Laboratoire associé au Centre National de Référence du VIH, CHU de Rouen, Rouen, France
    J Acquir Immune Defic Syndr 56:139-45. 2011
  8. ncbi A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection
    Marie Gueudin
    Laboratoire associé au Centre National de Référence du VIH, Hopital Charles Nicolle, CHU de Rouen, Rouen, France
    J Clin Microbiol 50:831-6. 2012
  9. ncbi A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes
    Josephine Braun
    Laboratoire de Virologie, Biostatistique, Centre Hospitalier Charles Nicolle, 1 rue de Germont, 76031 Rouen Cedex, France
    AIDS 17:331-6. 2003
  10. ncbi HIV-1 resistance genotyping on dried serum spots
    Jean Christophe Plantier
    Unité de virologie, Laboratoire associé au Centre National de Référence du VIH, Equipe d accueil 2656, CHU Charles Nicolle, Rouen, France
    AIDS 19:391-7. 2005

Collaborators

Detail Information

Publications31

  1. ncbi Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic
    Francis Barin
    Universite Francois Rabelais, Centre National de Référence du VIH and Inserm Espri EA 3856, Tours, France
    J Med Virol 78:S13-8. 2006
    ....
  2. ncbi Plasma RNA quantification and HIV-1 divergent strains
    Jean Christophe Plantier
    Laboratoire de Virologie, GRAM IFR 23 CHU Charles Nicolle, Rouen, France
    J Acquir Immune Defic Syndr 33:1-7. 2003
    ..In conclusion, the authors showed that the LCx kit allowed quantification of the large group M diversity and group O variants...
  3. ncbi Plasma viral RNA assay in HIV-1 group O infection by real-time PCR
    Marie Gueudin
    Laboratoire de Virologie, Hopital Charles Nicolle, 1 rue de Germont, 76031 Rouen, France
    J Virol Methods 113:43-9. 2003
    ..Despite the high initial cost of acquiring the required cycling device, the per-sample cost of this real-time quantitative PCR assay for HIV-1 group O is low, making it suitable for use in endemic zones...
  4. ncbi Differences in proviral DNA load between HIV-1- and HIV-2-infected patients
    Marie Gueudin
    Laboratoire de Virologie, CHU Charles Nicolle Rouen, France
    AIDS 22:211-5. 2008
    ....
  5. ncbi Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide
    Agnès Depatureaux
    Laboratoire associé au Centre National de Référence du VIH, EA2656, CHU Charles Nicolle, Rouen, France
    Antimicrob Agents Chemother 54:4016-9. 2010
    ..Enfuvirtide could therefore potentially be used in antiretroviral treatments for HIV-O-infected patients...
  6. ncbi French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002
    Diane Descamps
    Laboratoire de Virologie, CHU Bichat Claude Bernard, Paris, France
    J Acquir Immune Defic Syndr 38:545-52. 2005
    ..To survey the frequency of genotypic antiretroviral resistance and the spread of non-B subtypes in patients with primary HIV-1 infection (2001-2002) and in treatment-naive chronically HIV-1-infected patients (2001)...
  7. ncbi Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M
    Agnès Depatureaux
    Laboratoire associé au Centre National de Référence du VIH, CHU de Rouen, Rouen, France
    J Acquir Immune Defic Syndr 56:139-45. 2011
    ....
  8. ncbi A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection
    Marie Gueudin
    Laboratoire associé au Centre National de Référence du VIH, Hopital Charles Nicolle, CHU de Rouen, Rouen, France
    J Clin Microbiol 50:831-6. 2012
    ..Its detection limit is equivalent to that of commercial kits. This assay is cheap and suitable for use in areas in which strains of HIV-1 groups M and O cocirculate...
  9. ncbi A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes
    Josephine Braun
    Laboratoire de Virologie, Biostatistique, Centre Hospitalier Charles Nicolle, 1 rue de Germont, 76031 Rouen Cedex, France
    AIDS 17:331-6. 2003
    ..In developing countries, viral load assay is either unaffordable or hindered by on-site maintenance and/or technical problems...
  10. ncbi HIV-1 resistance genotyping on dried serum spots
    Jean Christophe Plantier
    Unité de virologie, Laboratoire associé au Centre National de Référence du VIH, Equipe d accueil 2656, CHU Charles Nicolle, Rouen, France
    AIDS 19:391-7. 2005
    ....
  11. ncbi HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide
    Diane Descamps
    AP HP, Groupe Hospitalier Bichat Claude Bernard, Laboratoire de Virologie, Paris F 75018, France
    J Antimicrob Chemother 62:451-5. 2008
    ..We studied gp41 mutations associated with failing enfuvirtide salvage therapy...
  12. ncbi Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays
    Jean Marie Sire
    Laboratoire de Virologie, Hôpital Saint Louis AP HP, INSERM U941, Universite Paris Diderot, Paris, France
    J Acquir Immune Defic Syndr 56:239-43. 2011
    ..A new version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 assay (CA/CTM v2.0) has been introduced to overcome the underquantification observed with the first version...
  13. ncbi Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes
    Marie Gueudin
    Laboratoire de Virologie, Equipe d accueil 2656, Centre Hospitalier Universitaire Charles Nicolle, 1 rue de Germont, 76031 Rouen, France
    J Acquir Immune Defic Syndr 44:500-5. 2007
    ..We also tested 88 plasma samples from patients infected with HIV-1 group M (B-D [n = 7], A-CRF01 [n = 16], CRF02 [n = 49], and other strains [n = 16])...
  14. ncbi HIV-1 and HIV-2 produce different amounts of 2-long terminal repeat circular DNA in vitro
    Marie Gueudin
    Laboratoire de virologie UPRES EA 2656 Laboratoire associé du centre de référence pour VIH, CHU Charles Nicolle 76031 ROUEN Cedex, France
    AIDS 22:2543-5. 2008
    ..This accumulation of HIV-2 2-LTR DNA points to less efficient host cell integration relative to HIV-1...
  15. ncbi Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France
    Diane Descamps
    Laboratoire de Virologie, AP HP Groupe hospitalier Bichat Claude Bernard and EA 4409 Université Paris Diderot Paris 7, Paris, France
    J Antimicrob Chemother 65:2620-7. 2010
    ..To estimate the prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-1-infected patients in France...
  16. ncbi Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study
    Cecile Henquell
    CHU de Clermont Ferrand, Centre de Biologie, Laboratoire de Virologie, F 63003 Clermont Ferrand, France
    Infect Genet Evol 11:496-503. 2011
    ..Phylodynamic analyses give a plausible reconstruction of the evolutionary history of HCV genotype 5a in France, suggesting the concomitant roles of transfusion, iatrogenic route and intra-familial transmission in viral diffusion...
  17. ncbi Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG
    Jean-Christophe Plantier
    Laboratoire de Virologie, Equipe d'Accueil 2639, , Tours, France
    J Clin Microbiol 40:1010-22. 2002
    ..This method can be adapted to the local situation by including only probes that correspond to the prevalent strains...
  18. ncbi Phenotypic susceptibility to nonnucleoside inhibitors of virion-associated reverse transcriptase from different HIV types and groups
    Edouard Tuaillon
    Laboratoire de Virologie, Centre Hospitalier Charles Nicolle, Rouen, France
    J Acquir Immune Defic Syndr 37:1543-9. 2004
    ..It would be particularly useful for large epidemiologic survey of the natural HIV polymorphism and the potential impact in emergence of drug resistance, particularly to nevirapine, widely used to prevent mother-to-child transmission...
  19. ncbi Virologic diagnosis and follow-up of children born to mothers infected by HIV-1 group O
    Marie Gueudin
    J Acquir Immune Defic Syndr 36:639-41. 2004
  20. ncbi Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR
    Jean Christophe Plantier
    Unité de virologie, Laboratoire associé au Centre National de Référence du VIH, Equipe d accueil 2656, CHU Charles Nicolle, 1 rue de Germont, 76031 Rouen, France
    J Clin Microbiol 42:5866-70. 2004
    ..3% of group A or B samples; isolate H was not detected. This method allowed rapid and specific discrimination between HIV-2 groups A and B and could be a useful tool for molecular epidemiological studies...
  21. ncbi HIV-1 group M superinfection in an HIV-1 group O-infected patient
    Jean-Christophe Plantier
    AIDS 18:2444-6. 2004
  22. ncbi Unequal detection of HIV type 1 group O infection by simple rapid tests
    Agnes Gautheret-Dejean
    Clin Infect Dis 46:1936-7. 2008
  23. ncbi Integrase polymorphism and HIV-1 group O diversity
    Marie Leoz
    AIDS 22:1239-43. 2008
  24. ncbi Monitoring of HIV-1 resistance in Tunisia (North Africa) with a dried plasma spot strategy
    Raoudha Dachraoui
    J Acquir Immune Defic Syndr 47:522-5. 2008
  25. ncbi Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France
    Caroline Semaille
    Institut de Veille Sanitaire, Saint Maurice, 94 415, France
    J Infect Dis 196:377-83. 2007
    ..New tools to better monitor dynamics of human immunodeficiency virus (HIV) transmission are needed...
  26. ncbi Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study
    Dominique Costagliola
    INSERM, Unité Mixte de Recherche UMR S 720, Universite Pierre et Marie Curie Paris 6, Paris, France
    J Acquir Immune Defic Syndr 46:12-8. 2007
    ..Surveillance of HIV-1 drug resistance in antiretroviral-treated patients is important from the public health perspective of the spread of resistance and to evaluate the proportion of patients for whom new drugs are needed...
  27. ncbi Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test
    Francois Rouet
    Laboratoire de Virologie, Centre Muraz, BP 390 Bobo Dioulasso 01, Burkina Faso
    J Acquir Immune Defic Syndr 45:380-8. 2007
    ..Addressing HIV-1 diversity, continual monitoring of HIV-1 RNA assays, together with molecular epidemiology studies, is required to improve the accuracy of all HIV RNA assays...
  28. ncbi Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa
    Jean Pierre Lombart
    , Ouagadougou, Burkina Faso
    AIDS 19:1273-7. 2005
    ..HDB-p24 use requires further evaluation before being considered as an alternative method in African HIV-infected patient follow up...
  29. ncbi Molecular epidemiology of hepatitis B virus in Dakar, Sénégal
    Muriel Vray
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    J Med Virol 78:329-34. 2006
    ..These results underline the importance of molecular characterization of HBV infection as specific treatments become available in this region...
  30. ncbi Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study
    Syria Laperche
    , , Institut National de la Transfusion Sanguine, 6 rue Alexandre-Cabanel, 75015 Paris, France
    J Clin Microbiol 43:733-9. 2005
    ....
  31. ncbi Generic screening test for HIV infection
    Jean-Christophe Plantier
    AIDS 20:1345-7. 2006